Market Research Logo

Global Tumor Ablation Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Global Tumor Ablation Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

The global tumor ablation market is expected to grow with the CAGR of approximately 12.8% during the forecast period (2016-2023). The market growth is primarily driven due to various factors such as increasing awareness regarding ablation procedures, increasing prevalence of cancer across the globe, technological innovations in thermal ablation technologies and increasing adoption of radiofrequency ablation. The radiofrequency ablation technology is expected to grow with the CAGR of approximately10.8% during the forecast period (2016-2023). Increasing awareness regarding the benefits associated with tumor ablation via. Radiofrequency such as its effectiveness, low risk of tissue damage as well as faster recovery is expected to propel its demand significantly in the forecast period. According to Radiology Info, RFA is a potential treatment option regarding patients who have problem with surgery and those, whose tumors are smaller than one and a half inch in diameter. The achievement rate for fully eliminating small liver tumors is higher than 85%.

Radiofrequency ablation is a feasible and effective option for the treatment and tumor ablation is a better option if surgery is not possible or risky or would not have sufficient liver tissue left for the organ in order to function sufficiently by following the surgical removal of a tumor. Furthermore, surgery is also risky in liver tumors that have not reacted to chemotherapy as well as small liver tumors which are excessively spread out to be eliminated surgically. The use of radiofrequency ablation technology is increasing its popularity that is also expected to enhance its adoption rate in the upcoming years. However, strict government regulations and high cost associated with the technology are hindering the growth of tumor ablation market. Increasing healthcare infrastructure in developing countries and increasing medical tourism across the globe is expected to create good opportunity for the market growth. On the basis of geography, North America occupied major share, in terms of revenue in 2016 due to increasing expenditure for healthcare services in the region as well as increasing prevalence of cancer in the region. However, Asia Pacific is expected to be the fastest growing region for the tumor ablation market due to increasing awareness regarding minimally-invasive procedures in the region as well as increasing government focus to develop better healthcare infrastructure in the region. The presence of major players such as Boston Scientific Corporation (U.S.), Ethicon, Inc. (U.S.), Health Tronics, Inc. (U.S.), Integra Lifesciences Holdings Corporation (U.S.), Medtronic PLC (U.S.) etc. are creating opportunity for large innovations in tumor ablation therapies which will further increase demand of tumor ablation therapies.

The global tumor ablation market is segmented on the basis of application, technology and mode of treatment. The application segment is further categorized into liver cancer, kidney cancer, lung cancer, bone metastasis and others. The technology segment is further classified into radiofrequency (RF) ablation, cryoablation, microwave ablation and other technologies. The mode of treatment is further segmented into laparoscopic ablation, percutaneous ablation, and surgical ablation.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL TUMOR ABLATION MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. INCREASING AWARENESS REGARDING ABLATION PROCEDURES
3.1.2. INCREASING PREVALENCE OF CANCER ACROSS THE GLOBE
3.1.3. TECHNOLOGICAL ADVANCEMENTS IN ABLATION DEVICES
3.1.4. INCREASING ADOPTION OF RADIOFREQUENCY ABLATION
3.2. MARKET RESTRAINTS
3.2.1. STRICT GOVERNMENT REGULATIONS
3.2.2. HIGH COST ASSOCIATED WITH THE TECHNOLOGY
3.3. MARKET OPPORTUNITIES
3.3.1. INCREASING HEALTHCARE INFRASTRUCTURE IN DEVELOPING COUNTRIES
3.3.2. INCREASING MEDICAL TOURISM ACROSS THE GLOBE
3.4. MARKET CHALLENGES
3.4.1. LACK OF SKILLED PROFESSIONALS
4. MARKET SEGMENTATION
4.1. GLOBAL TUMOR ABLATION MARKET BY APPLICATION
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL TUMOR ABLATION MARKET IN LIVER CANCER
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL TUMOR ABLATION MARKET IN KIDNEY CANCER
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL TUMOR ABLATION MARKET IN LUNG CANCER
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.1.5.4. GLOBAL TUMOR ABLATION MARKET IN BONE METASTASIS
4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.4.4. KEY CONCLUSIONS
4.1.5.5. GLOBAL TUMOR ABLATION MARKET IN OTHERS
4.1.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.5.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.5.4. KEY CONCLUSIONS
4.2. GLOBAL TUMOR ABLATION MARKET BY TECHNOLOGY
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL RADIOFREQUENCY (RF) ABLATION MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL CRYOABLATION MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL MICROWAVE ABLATION MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. GLOBAL OTHER TECHNOLOGIES MARKET
4.2.5.4.1. APPLICATION
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSIONS
4.3. GLOBAL TUMOR ABLATION MARKET BY MODE OF TREATMENT
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL LAPAROSCOPIC ABLATION MARKET
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL PERCUTANEOUS ABLATION MARKET
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. GLOBAL SURGICAL ABLATION MARKET
4.3.5.3.1. APPLICATION
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITIONS
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL TUMOR ABLATION MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. ANGIODYNAMICS, INC. (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. BOSTON SCIENTIFIC CORPORATION (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
7.3. BTG INTERNATIONAL LTD (UK)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. BVM MEDICAL LTD (UK)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. COMSOL, INC. (U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.6. EDAP TMS S.A. (FRANCE)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7. ETHICON, INC. (U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
7.8. GALIL MEDICAL, INC. (U.S.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS
7.9. HEALTH TRONICS, INC. (U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.9.6. STRATEGIC ANALYSIS
7.10. INTEGRA LIFESCIENCES HOLDINGS CORPORATION (U.S.)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. INTIO, INC. (U.S.)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. MEDTRONIC PLC (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. MERMAIL MEDICAL A/S (DENMARK)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. SONACARE MEDICAL A/S (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. ST. JUDE MEDICAL, INC. (U.S.)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL TUMOR ABLATION MARKET BY APPLICATION 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET FOR LIVER CANCER BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET FOR KIDNEY CANCER BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET FOR LUNG CANCER BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET FOR BONE MESTASIS BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET FOR OTHERS BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
GLOBAL RADIOFREQUENCY (RF) ABLATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL CRYOABLATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL MICROWAVE ABLATION MARKET BY PLATFORM 2014-2023 ($ MILLION)
GLOBAL OTHER TECHNOLOGIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY MODE OF TREATMENT 2014-2023 ($ MILLION)
GLOBAL LAPAROSCOPIC ABLATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL PERCUTANEOUS ABLATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL SURGICAL ABLATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
NORTH AMERICA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
EUROPE TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
ASIA PACIFIC TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
REST OF THE WORLD TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
LIST OF FIGURES
GLOBAL TUMOR ABLATIONMARKET BY LIVER CANCER 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY KIDNEY CANCER 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY LUNG CANCER 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY BONE MESTASIS 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY OTHERS 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY RADIOFREQUENCY (RF) ABLATION 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY CRYOABLATION 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY MICROWAVE ABLATION 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY OTHER TECHNOLOGIES 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY LAPAROSCOPIC ABLATION 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY PERCUTANEOUS ABLATION 2014-2023 ($ MILLION)
GLOBAL TUMOR ABLATION MARKET BY SURGICAL ABLATION 2014-2023 ($ MILLION)
UNITED STATES (U.S.) TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
CANADA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
UNITED KINGDOM (UK) TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
FRANCE TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
GERMANY TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
SPAIN TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
ROE TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
INDIA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
CHINA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
JAPAN TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
AUSTRALIA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
ROAPAC TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
LATIN AMERICA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)
MENA TUMOR ABLATION MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report